Better lives through natural healthcare

Cardiometabolic Health: Underlying Network Mechanisms

Cardiometabolic diseases are the number one cause of death in Australia and globally.1 An estimated 646,000 years of healthy life have been lost in 2018 due to all forms of cardiovascular disease,2 with these numbers continuing to increase at an alarming rate.3 The regulatory network of cardiometabolic dysfunction has a distinct architecture, with multi-system drivers throughout specific organs and organ systems, cells, and the genome. Cross-talk between the metabolome and the microbiome is part of this network, communicating via secondary metabolites such as triethylamine-N-oxide (TMAO), secondary bile acids, short-chain fatty acids, and aromatic amino acids. Innovative cardiometabolic plasma markers can detect disruptions to the metabolome and microbiome years before clinical manifestation of disease. The confirmation of prodromal stages in dysfunction suggests an opportunity for early therapeutic intervention and even prevention. This presentation will discuss: • How specific herbs and nutrients are metabolised and their corresponding key target pathways • The role of secondary metabolites and the microbiome in cardiometabolic health • Identification of subtle nuances in pathology markers to determine cardiometabolic risk at various stages of dysfunction • Clinical presentations and recognition of early warning signs of dysfunction References 1. CSIRO Nutrition & Health. Cardiometabolic Health. n.d. Retrieved from: https://research.csiro.au/nutritionandhealth/research-groups/nutrition-and-health-substantiation/our-science/cardiometabolic-health/ 2. Australian Institute of Health & Welfare. Heart, stroke and vascular disease-Australian facts. 2021. Retrieved from: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/impacts/burden-of-cardiovascular-disease 3. Roth GA et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25): 2982-3021. doi: 10.1016/j.jacc.2020.1101

Oncology: Supportive Integrative Therapies

Oncology: Supportive Integrative Therapies.  Cancer has been referred to as the emperor of all maladies. This is a fitting phrase when we consider the nature of the disease, the prolonged treatments, and the fear of the future, all of which have a dramatic psychological impact on the patient and their loved ones. For the naturopathic practitioner, these factors can often make supporting the cancer patient potentially daunting and challenging. Overwhelmingly the cancer burden has been linked to environmental and lifestyle factors. As naturopathic practitioners, we are uniquely positioned to provide education around these modifiable factors and support patients undergoing conventional treatment. Most importantly, we can be a source of holistic, evidence-based information at a time when patients feel confused and overwhelmed. Join us on 26 and 27 August in Brisbane or via live stream where an esteemed panel of holistic practitioners, researchers and experts in the field of supportive oncology care will discuss: • The many stages and hallmarks of cancer • Holistic and systematic approaches to support patients through their cancer journey • Lifestyle drivers and potential modifications for improved therapeutic outcomes • Trauma informed practice and care Early-bird prices finish on 30 June 2023.

Integria Practitioner 2023 Education Calendar